April 30th 2025
A large cohort study shows that buprenorphine treatment during pregnancy significantly lowers the risk of preterm birth, severe maternal morbidity, and neonatal complications in women with opioid use disorder.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
US bill for false-positive mammograms: $4 billion annually
April 8th 2015A recent report sheds light on how much false-positives and overdiagnosis of breast cancer cost. Additionally, new research examines the impact of the number of live births on future heart health in the mother and provides further evidence of the efficacy of cfDNA testing.
Read More
UK approves three-parent fertility treatments and more research
February 11th 2015A form of assisted reproductive technology that could make it possible for women with mutations in mitochondrial DNA to give birth to children free of mitochondrial disease has been approved by UK’s House of Commons. A Food and Drug Administration (FDA) committee is considering granting similar approval for use of the technique-known as oocyte modification or three-parent gene therapy-in the United States.
Read More
SMFM Clinical Guideline: Nonimmune Hydrops Fetalis
February 6th 2015A summary of the evidence-based SMFM guidelines for the evaluation and management of nonimmune hydrops fetalis (NIHF). The guidelines cover the epidemiology, risk factors, work-up, prognosis, and treatment of pregnancies complicated by NIHF.
Read More
Tighter prenatal hypertension control doesn’t result in larger babies, later births
February 4th 2015Tight control of hypertension in pregnancy does not produce better perinatal outcomes or fewer serious maternal complications than looser control, according to results of an international randomized clinical trial. Published in the New England Journal of Medicine, the findings are consistent with those from a meta-analysis of 29 previous trials.
Read More
FDA updates labeling of drugs for pregnant and lactating women
December 10th 2014The US Food and Drug Administration (FDA) recently issued a final rule altering how the labels for physicians on prescription drugs and biological products provide information for pregnant and breastfeeding women.
Read More
AAGL Stump the Professors Score: Experts 1, Presenters 2
November 21st 2014A panel of experts were bested only once at the “Stump the Professors” session at the 43rd AAGL Global Congress on Minimally Invasive Gynecology in Vancouver. A sarcoma was the diagnosis that got away among three complex cases presented to a packed audience.
Read More
Does cryopreservation of embryos increase risk of placenta accreta?
November 19th 2014A small study by investigators from Harvard University suggests that cryopreserved embryo transfer (CET) is a strong independent risk factor for placenta accreta in women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).
Read More
March of Dimes report: US preterm birth rate at 17-year low
November 14th 2014The 7th annual March of Dimes Premature Birth Report Card shows that in 2013, the preterm birth rate fell to its lowest in 17 years-11.5%--meeting Healthy People 2020 goals. That number, however, still earns a “C” grade from the organization, which has set a goal of 9.6% of all live births by 2020.
Read More